Comet assay: a method to evaluate genotoxicity of nano-drug delivery system

Somayeh Vandghanooni1, Morteza Eskandani

  • 1Research Center for Pharmaceutical Nanotechnology, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Bioimpacts : BI
|May 17, 2013
PubMed
Abstract

Insights

The comet assay, a sensitive method for detecting DNA strand breaks, is valuable for genotoxicity studies of drug delivery systems. It helps assess cellular toxicity induced by nanomaterials.

Area of Science:

  • Biomedical Science
  • Toxicology
  • Nanotechnology

Background:

  • Drug delivery systems, particularly those using nanomaterials, can cause cellular toxicity.
  • DNA damage is a primary mechanism underlying nanomaterial-induced toxicity.
  • The comet assay (single cell gel electrophoresis, SCGE) is a sensitive technique for detecting DNA strand breaks.

Purpose of the Study:

  • To review recent research on the application of the comet assay in drug delivery systems.
  • To evaluate the potential of the comet assay for assessing DNA damage in genotoxicity studies.

Main Methods:

  • Literature review of drug delivery studies utilizing the comet assay.
  • Explanation of the comet assay principle: embedding cells in agarose, lysis, alkaline electrophoresis, and DNA migration to form a 'comet tail'.

Main Results:

  • The comet assay is widely used due to its sensitivity in detecting DNA damage.
  • Comet images can arise from apoptosis-mediated nuclear fragmentation.
  • The assay visualizes DNA strand breaks through the migration of relaxed DNA loops.

Conclusions:

  • The comet assay is a powerful tool for evaluating DNA damage.
  • It serves as an informative platform for genotoxicity assessment of drug delivery systems.
  • This review highlights the assay's potential in ensuring the safety of nanomaterial-based drug delivery.

Related Concept Videos